Minerva Imaging and TD2 partner for radiopharmaceutical development support
The partnership aims to offer sponsors a faster, coordinated path from translational research to first-in-human trials.
See the latest news and media coverage for Minerva Imaging. We track all announcements, press releases, and industry mentions in real time, all in one place.
Integrated CRO and CDMO for translational oncology research
minervaimaging.comLast updated
In short: Minerva Imaging expanded its radiopharmaceutical platform through strategic partnerships, isotope supply growth, and an investment from Nordic Capital.
The partnership aims to offer sponsors a faster, coordinated path from translational research to first-in-human trials.
The integration of AbYlink enables one-step conjugation to antibodies, expanding capabilities for theranostics and biologic-based radiopharmaceutical formats.
The acquisition expands capabilities for alpha-emitting radiopharmaceutical imaging, enhancing preclinical support for clients in actinium therapies. CEO Carsten H. Nielsen highlights its importance for biodistribution data.
Publication evaluates preclinical biodistribution, tolerability, and efficacy of [161Tb]Tb-trastuzumab in HER2-expressing breast cancer tumors. Results show high tumor uptake and growth suppression.
Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine...
XenoSTART & Minerva Imaging expand partnership to deliver integrated PDX-radiopharmaceutical drug development platform: San Antonio, Texas Monday, October 6, 2025, 10:00 Hrs [IST...
The START Center for Cancer Research, its preclinical arm XenoSTART, and Denmark-based Minerva Imaging have expanded their decade-long partnership.
ØLSTYKKE, Denmark, June 10, 2025 /PRNewswire/ -- The investment will be made in close partnership with the founders of Minerva, marking a joint commitment to...
Track Minerva Imaging and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.